High-performance liquid chromatography with mass spectrometry detection for quantitating COL-3, a chemically modified tetracycline, in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 22, Issue 6, 2000, Pages 1003-1014

  Rudek, Michelle A ^a   March, Clark L ^b   Bauer Jr, Kenneth S ^a   Pluda, James M ^a   Figg, William D ^a  

^a Division of Clinical Sciences   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Chromatography; COL 3; Mass spectrometry; Tetracycline

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; MATRIX METALLOPROTEINASE INHIBITOR; TETRACYCLINE DERIVATIVE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALIBRATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRECIPITATION; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; FREEZING; HUMANS; MASS SPECTROMETRY; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; QUALITY CONTROL; TETRACYCLINE; TETRACYCLINES;

EID: 0034058133     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00257-0     Document Type: Article

References (8)

1. Stetler-Stevenson W.G., Hewitt R., Corcoran M. Semin. Cancer Biol. 7:1996;147-154.
2. Seftor R.E.B., Seftor E.A., DeLarco J.E. et al. Clin. Exp. Metastasis. 16:1998;217-225.
3. Lokeshwar B.L., Houston-Clark H.L., Selzer M.G. et al. Adv. Dent. Res. 12:1998;97-102.
4. Marsh J.R., Weiss P.J. J. Assoc. Off. Anal. Chem. 50:1967;457-462.
5. Blanchflower W.J., McCracken R.J., Haggan A.S. et al. J. Chromatogr. B. 692:1997;351-360.
6. Kijak P.J., Leadbetter M.G., Thomas M.H. et al. Biol. Mass. Spectrom. 20:1991;789-795.
7. Watanabe R., Wender S.H. Arch. Biochem. Biophys. 112:1965;111-114.
8. S. Budavari (Ed.), The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals, eleventh ed. Merck, Rahway, NJ, 1989, pp. 350-351.